Form 4: Boston Scientific Director John E. Sununu Receives Equity Award

Director John E. Sununu received an annual equity award of 2,081 shares of Boston Scientific common stock on May 8, 2025.

Summary

• On May 8, 2025, John E. Sununu, a director of Boston Scientific Corp, acquired 2,081 shares of common stock as an annual equity award.
• The shares were granted at a price of $0.0000 per share.
• Following the transaction, Sununu beneficially owns 54,723 shares of Boston Scientific common stock.
• The equity award is in the form of restricted stock that vests in full upon the next annual meeting of stockholders.
• The value of the award is $215,000, calculated by dividing this amount by the closing price of the common stock on the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard corporate governance practice of awarding equity to directors, which is generally viewed favorably as it aligns their interests with shareholders.

Positives

• The equity award demonstrates Boston Scientific's commitment to aligning director interests with shareholder value.
• The vesting schedule tied to the annual meeting of stockholders encourages long-term engagement.

Future Outlook

The restricted stock vests upon the next annual meeting of stockholders, indicating a future event tied to the company's performance and shareholder engagement.

Industry Context

Equity awards are a common practice in corporate governance to incentivize directors and align their interests with those of the shareholders. The size and structure of the award are typical for directors of publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• Companies like Medtronic (MDT) and Abbott Laboratories (ABT) also use equity awards as part of their director compensation.
• The vesting schedule tied to the annual meeting is a standard practice to ensure directors remain engaged and accountable.

Stakeholder Impact

• Shareholders may view the equity award positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to act in the best interest of the company to ensure the stock performs well.

Next Steps

• The restricted stock will vest upon the next annual meeting of stockholders.

Key Dates

Keywords

equity award, director, common stock, Boston Scientific, BSX, Sununu, restricted stock, beneficial ownership